These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9740071)

  • 1. S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
    Cascinu S; Ligi M; Graziano F; Del Ferro E; Valentini M; Grianti C; Bartolucci M; Catalano G
    Cancer; 1998 Sep; 83(6):1081-5. PubMed ID: 9740071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy.
    Cascinu S; Graziano F; Catalano V; Valentini M; Rossi MC; Baldelli AM; Ghiselli R; Saba V; Giordani P; Catalano G
    Anticancer Res; 2000; 20(5C):3839-42. PubMed ID: 11268464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome.
    Rupa JD; de Bruïne AP; Gerbers AJ; Leers MP; Nap M; Kessels AG; Schutte B; Arends JW
    Cancer; 2003 May; 97(10):2404-11. PubMed ID: 12733138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
    Cascinu S; Staccioli MP; Gasparini G; Giordani P; Catalano V; Ghiselli R; Rossi C; Baldelli AM; Graziano F; Saba V; Muretto P; Catalano G
    Clin Cancer Res; 2000 Jul; 6(7):2803-7. PubMed ID: 10914727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
    Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N
    Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [S-phase fraction and malignant potential in DNA diploid colorectal cancer].
    Ando Y; Tsuchiya A; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):771-4. PubMed ID: 8489284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL; Ho JW; Chan R; Au G; Chu KW
    Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.